...
【24h】

Adipocytokines: The pied pipers

机译:脂肪细胞因子:吹笛者

获取原文
           

摘要

Even though there have been major advances in therapy, atherosclerosis and coronary artery disease retain their lead as one of the major causes of morbidity and mortality in the first decade of 21st century. To add to the woes, we have diabetes, obesity and insulin resistance as the other causes. The adipose tissue secretes several bioactive mediators that influence inflammation, insulin resistance, diabetes, atherosclerosis and several other pathologic states besides the regulation of body weight. These mediators are mostly proteins and are termed “adipocytokines”. Adiponectin, resistin, visfatin, retinol binding protein-4 (RBP-4) and leptin are a few such proteins. Adiponectin is a multimeric protein, acting via its identified receptors, AdipoR1 and AdipoR2. It is a potential biomarker for metabolic syndrome and has several antiinflammatory actions. Adiponectin increases insulin sensitivity and ameliorates obesity. Resistin, another protein secreted by the adipose tissue, derived its name due to its involvement in the development of insulin resistance. It plays a role in the pathophysiology of several conditions because of its robust proinflammatory activity mediated through the activation of extracellular signal regulated kinases 1 and 2 (ERK 1/2). In 2007, resistin was reported to have protective effect in ischemia-reperfusion injury and myocyte-apoptosis in the setting of myocardial infarction (MI). RBP-4 is involved in the developmental pathology of type 2 diabetes mellitus and obesity. Visfatin has been described as an inflammatory cytokine. Increased expression of visfatin mRNA has been observed in inflammatory conditions like atherosclerosis and inflammatory bowel disease. Leptin mainly regulates the food intake and energy homeostasis. Leptin resistance has been associated with development of obesity and insulin resistance. Few drugs (thiazolidinediones, rimonabant, statins, etc.) and some lifestyle modifications have been found to improve the levels of adipocytokines. Their role in therapy has a lot in store to be explored upon.Keywords: Adipokine, adiponectin, leptin, resistin, retinol binding protein-4, visfatin
机译:尽管治疗取得了重大进展,但动脉粥样硬化和冠状动脉疾病仍然是导致21世纪前十年发病率和死亡率的主要原因之一。更糟糕的是,我们还有其他原因导致糖尿病,肥胖和胰岛素抵抗。脂肪组织分泌一些生物活性介质,这些介质除了调节体重外,还影响炎症,胰岛素抵抗,糖尿病,动脉粥样硬化和其他几种病理状态。这些介体主要是蛋白质,被称为“脂肪细胞因子”。脂联素,抵抗素,visfatin,视黄醇结合蛋白4(RBP-4)和瘦素就是其中一些蛋白。脂联素是一种多聚体蛋白,通过其识别的受体AdipoR1和AdipoR2起作用。它是代谢综合征的潜在生物标志物,具有多种抗炎作用。脂联素增加胰岛素敏感性并改善肥胖症。抵抗素是脂肪组织分泌的另一种蛋白质,因其参与胰岛素抵抗的发展而得名。由于它通过细胞外信号调节激酶1和2(ERK 1/2)的激活介导了强大的促炎活性,因此它在多种疾病的病理生理学中都发挥着作用。在2007年,据报道抵抗素在心肌梗塞(MI)的环境中对缺血-再灌注损伤和心肌细胞凋亡具有保护作用。 RBP-4参与2型糖尿病和肥胖的发展病理。 Visfatin已被描述为一种炎症细胞因子。在诸如动脉粥样硬化和炎性肠病的炎性病症中已经观察到visfatin mRNA的表达增加。瘦素主要调节食物的摄取和能量稳态。瘦素抵抗已与肥胖和胰岛素抵抗的发展有关。很少有药物(噻唑烷二酮,利莫那班,他汀类药物等)和某些生活方式的改变可改善脂肪细胞因子的水平。它们在治疗中的作用尚有待探索。关键词:脂肪因子,脂联素,瘦素,抵抗素,视黄醇结合蛋白4,visfatin

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号